Assessments of neuropsychiatric, neurocognitive and psychosocial alterations clinical trials

Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway

This study looks at brain changes, like memory or mood problems, in lung cancer patients taking new targeted medicines. It aims to understand these side effects better and improve care, working with patients.